Denali Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Denali Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 205% to $330,531,000. The net income raised on -$145,224,000 and profit margin reached -44%. Total operating expenses were $527,230,000.
Profit Margin
| 2015 | 0 | -16.78M | |
|---|---|---|---|
| 2016 | 0 | -86.65M | |
| 2017 | 0 | -88.18M | |
| 2018 | 129.16M | -36.24M | -28.06% |
| 2019 | 26.67M | -197.61M | -740.74% |
| 2020 | 335.65M | 71.13M | 21.19% |
| 2021 | 48.66M | -290.58M | -597.15% |
| 2022 | 108.46M | -325.99M | -300.56% |
| 2023 | 330.53M | -145.22M | -43.94% |
DNLI Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 330.53M | 108.46M | 48.66M | 335.65M | 26.67M | 129.16M | 0 | 0 | 0 |
Cost of revenue | 16.72M | 7.03M | 5.60M | 212.61M | 193.38M | 0 | 3.08M | 0 | 121K |
Gross profit | 313.80M | 101.43M | 43.05M | 123.04M | -166.70M | 129.16M | -3.08M | 0 | -121K |
Operating exp. | |||||||||
Research and development | 423.87M | 358.73M | 265.35M | 212.61M | 193.38M | 143.18M | 74.46M | 75.70M | 11.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 527.23M | 449.20M | 344.41M | 272.94M | 239.86M | 175.53M | 90.14M | 87.43M | 16.67M |
Operating income | -196.69M | -340.74M | -295.75M | 62.71M | -213.18M | -46.37M | -90.14M | -87.43M | -16.67M |
Other income (expenses), net | 51.50M | 14.77M | 4.59M | 9.24M | 15.21M | 10.13M | 1.95M | 781K | -109K |
Income before tax | -145.19M | -325.97M | -291.15M | 71.95M | -197.96M | -36.24M | -88.18M | -86.65M | -16.78M |
Income tax expense | 30K | 21K | -575K | 823K | -351K | 10.13M | -3.08M | 0 | 0 |
Net income | -145.22M | -325.99M | -290.58M | 71.13M | -197.61M | -36.24M | -88.18M | -86.65M | -16.78M |
Earnings per share | |||||||||
Basic EPS | -1.06 | -2.6 | -2.39 | 0.65 | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
Diluted EPS | -1.06 | -2.6 | -2.39 | 0.63 | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |